Wayne State University
Wayne State University
Detroit, Michigan, United States26 results · Page 1 of 2
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| An Open-label Study of XEN1101 in Epilepsy | Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Tonic-Clonic Seizures, brain disorder, central nervous system disorder, epilepsy, focal epilepsy, nervous system disorder, visual epilepsy | Enrolling by invitation | Phase 3 | 2026-10-08 | NCT05718817 | |
| A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures | brain disorder, central nervous system disorder, epilepsy, nervous system disorder | Recruiting | Phase 3 | 2026-10-08 | NCT05667142 | |
| A Study to Evaluate the Efficacy and Safety of Cannabidiol Oral Solution (CBD-OS [GWP42003-P, JZP926]) for the Treatment of Focal-Onset Seizures | Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Seizures, Focal, Signs and Symptoms, nervous system disorder, visual epilepsy | Recruiting | Phase 1 | 2026-10-02 | NCT07233239 | |
| A Clinical Study to Evaluate Ianalumab in Participants With Diffuse Cutaneous Systemic Sclerosis | Skin and Connective Tissue Diseases, connective tissue disorder, diffuse scleroderma, skin disorder, systemic sclerosis | Recruiting | Phase 2 | 2026-09-28 | NCT06470048 | |
| Couples Motivational Interviewing to Reduce Drug Use and HIV Risk in Vulnerable Male Couples | Blood-Borne Infections, Chemically-Induced Disorders, Genital Diseases, HIV infectious disease, Infections, RNA Virus Infections, Substance Use, Urogenital Diseases, immune system disorder, inborn error of immunity, infectious disease, lentivirus infection, psychiatric disorder, sexually transmitted disease, substance-related disorder, uterine carcinosarcoma, viral infectious disease, viral sexually transmitted disease | Recruiting | Not applicable | 2026-09-17 | NCT06307977 | |
| A Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Ocrelizumab in Adult Participants With Primary Progressive Multiple Sclerosis | CNS demyelinating autoimmune disease, Chronic Disease, Disease Attributes, Multiple Sclerosis, Primary Progressive, Pathologic Processes, Pathological Conditions, Signs and Symptoms, autoimmune disease, autoimmune disorder of the nervous system, chronic progressive multiple sclerosis, demyelinating disease, immune system disorder, multiple sclerosis, nervous system disorder | Active, not recruiting | Phase 3 | 2026-09-17 | NCT04544449 | |
| Sacral Neuromodulation for Male Overactive Bladder (MOAB) | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Lower Urinary Tract Symptoms, Male Urogenital Diseases, Neoplasms by Site, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Urogenital Diseases, Urogenital Neoplasms, Urological Manifestations, benign prostatic hyperplasia, male reproductive organ cancer, male reproductive system disorder, neoplasm, overactive bladder, prostate cancer, prostate disorder, urinary bladder disorder, urinary system disorder | Recruiting | Not applicable | 2026-09-14 | NCT06511141 | |
| An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230) | Infarction, Necrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, heart disorder, ischemic disease, myocardial infarction, myocardial ischemia, nervous system disorder, stroke disorder, vascular disorder | Recruiting | Phase 3 | 2026-09-04 | NCT07517263 | |
| Project 2: ACHIEVE- HF | cardiovascular disorder, heart disorder, heart failure, hypertensive disorder, vascular disorder | Active, not recruiting | Not applicable | 2026-09-01 | NCT05330221 | |
| Safety, Efficacy and Tolerability of Ianalumab Versus Placebo, Combination With SoC Therapy, in Participants With Active Lupus Nephritis | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Skin and Connective Tissue Diseases, Urogenital Diseases, autoimmune disease, connective tissue disorder, glomerulonephritis, immune system disorder, kidney disorder, lupus nephritis, nephritis, systemic lupus erythematosus, urinary system disorder | Active, not recruiting | Phase 3 | 2026-08-21 | NCT05126277 | |
| Safety and Efficacy of Fingolimod in Pediatric Patients With Multiple Sclerosis | Body Weight, CNS demyelinating autoimmune disease, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Thinness, autoimmune disease, autoimmune disorder of the nervous system, demyelinating disease, immune system disorder, multiple sclerosis, nervous system disorder | Active, not recruiting | Phase 3 | 2026-08-10 | NCT01892722 | |
| Warrior CARE: Cannabis Behavioral Health | Chemically-Induced Disorders, Stress Disorders, Traumatic, acute stress disorder, cannabis dependence, post-traumatic stress disorder, psychiatric disorder, substance-related disorder | Recruiting | Phase 1 / Phase 2 | 2026-08-07 | NCT06381180 | |
| A Rollover Study to Evaluate the Long-Term Safety and Efficacy of Ocrelizumab In Patients With Multiple Sclerosis | CNS demyelinating autoimmune disease, autoimmune disease, autoimmune disorder of the nervous system, demyelinating disease, immune system disorder, multiple sclerosis, nervous system disorder | Active, not recruiting | Phase 3 | 2026-07-29 | NCT05269004 | |
| Follow-up Visit of High Risk Infants | Female Urogenital Diseases and Pregnancy Complications, Obstetric Labor Complications, Obstetric Labor, Premature, Premature Birth, Urogenital Diseases, pregnancy disorder | Recruiting | Not stated | 2026-07-01 | NCT00009633 | |
| Genomic Predictors of Recurrent Pregnancy Loss | Recurrent Pregnancy Loss | Recruiting | Not stated | 2026-05-22 | NCT05444283 | |
| A Study to Evaluate the Safety (Compared to Iron Sucrose), Efficacy and Pharmacokinetics of Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric Subjects With Chronic Kidney Disease (CKD) | Anemia, Hypochromic, Chronic Disease, Disease Attributes, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Hemic and Lymphatic Diseases, Iron Deficiencies, Male Urogenital Diseases, Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Urogenital Diseases, anemia, chronic renal failure syndrome, hematologic disorder, iron deficiency anemia, iron metabolism disease, kidney disorder, kidney failure, metabolic disease, urinary system disorder | Recruiting | Phase 3 | 2026-04-17 | NCT03619850 | |
| Generic Database of Very Low Birth Weight Infants | Female Urogenital Diseases and Pregnancy Complications, Obstetric Labor Complications, Obstetric Labor, Premature, Premature Birth, Urogenital Diseases, pregnancy disorder | Recruiting | Not stated | 2026-03-16 | NCT00063063 | |
| A Study of Zasocitinib in Adults With Hidradenitis Suppurativa | Bacterial Infections and Mycoses, Infections, Skin and Connective Tissue Diseases, Suppuration, bacterial infectious disease, hidradenitis, hidradenitis suppurativa, skin disease caused by bacterial infection, skin disorder, skin disorder caused by infection, sweat gland disorder | Recruiting | Phase 2 | 2026-03-06 | NCT07244263 | |
| TNF-α Treatment of Blast-Induced Tinnitus | Ear Diseases, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Sensation Disorders, Signs and Symptoms, Tinnitus, Noise Induced, hearing disorder, nervous system disorder, otorhinolaryngologic disease, tinnitus | Recruiting | Phase 2 | 2026-02-23 | NCT04066348 | |
| VR Stimulation of Exercise Response in Sedentary Humans | Insulin Resistance, Nutritional and Metabolic Diseases, glucose metabolism disease, hyperinsulinism, metabolic disease | Recruiting | Not applicable | 2025-12-23 | NCT07296991 | |
| Aspirin in Reducing Events in the Elderly-Extension (ASPREE-XT) | Frailty, Hemorrhage, Pathologic Processes, Pathological Conditions, Signs and Symptoms, brain disorder, cancer, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, cognitive disorder, dementia, depressive disorder, heart disorder, neoplasm, nervous system disorder, psychiatric disorder, stroke disorder, vascular disorder | Active, not recruiting | Not stated | 2025-11-04 | NCT07224347 | |
| Study to Assess the Safety of Amantadine Hydrochloride (HCl) Intravenous (IV) Solution (MR-301) in Patients With Severe Traumatic Brain Injury (TBI). | Brain Injuries, Traumatic, Craniocerebral Trauma, brain disorder, brain injury, central nervous system disorder, injury, nervous system disorder, nervous system injury | Active, not recruiting | Phase 2 | 2025-07-15 | NCT06253923 | |
| Functional Brain Mapping for Patients with Epilepsy | brain disorder, central nervous system disorder, epilepsy, nervous system disorder | Recruiting | Not applicable | 2025-02-26 | NCT05755919 | |
| Clinical Phenotyping Resource and Biobank Core of the Michigan O'Brien Renal Center | Chronic Disease, Disease Attributes, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Urination Disorders, Urogenital Diseases, Urological Manifestations, chronic renal failure syndrome, glomerular disorder, glomerulonephritis, kidney disorder, kidney failure, nephritis, nephrosis, nephrotic syndrome, proteinuria, urinary system disorder | Recruiting | Not stated | 2024-10-04 | NCT01016613 | |
| Enroll -HD: A Prospective Registry Study in a Global Huntington's Disease Cohort | Cognition Disorders, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyskinesias, Huntington disease, basal ganglia disorder, brain disorder, central nervous system disorder, choreatic disease, cognitive disorder, dementia, hereditary disease, inherited neurodegenerative disorder, movement disorder, nervous system disorder, neurodegenerative disease, psychiatric disorder | Recruiting | Not stated | 2024-02-28 | NCT01574053 |